Net realized losses on investments (including $6.7, $25.1 and $17.0 of impairment-related losses for the years ended December 31, 2025, 2024 and 2023, respectively) and fair value changes to equity securities
-$71.8M+5.3%
-$75.8M-10.3%
-$68.7M+61.8%
-$179.7M
Total revenues
$12.81B+7.9%
$11.88B+6.7%
$11.13B+9.2%
$10.19B
Policyholder benefits
$2.93B+5.8%
$2.77B+9.7%
$2.52B+6.9%
$2.36B
Underwriting, selling, general and administrative expenses
$8.69B+7.6%
$8.08B+5.0%
$7.70B+4.5%
$7.37B
Interest expense
$109.7M+2.5%
$107.0M-0.9%
$108.0M-0.3%
$108.3M
Loss (gain) on extinguishment of debt (Note 18)
$1.3M
$0+100.0%
-$100K-111.1%
$900K
Total benefits, losses and expenses
$11.73B+7.1%
$10.95B+6.1%
$10.32B+4.9%
$9.84B
Income before income tax expense
$1.09B+17.3%
$927.3M+14.9%
$806.8M+130.6%
$349.9M
Income tax expense
$214.7M+28.5%
$167.1M+1.7%
$164.3M+124.1%
$73.3M
Net income
$872.7M+14.8%
$760.2M+18.3%
$642.5M+132.3%
$276.6M
Basic (in dollars per share)
$17140000.00+17.8%
$14550000.00+21.0%
$12020000.00+136.1%
$5090000.00
Diluted (in dollars per share)
$16930000.00+17.1%
$14460000.00+21.0%
$11950000.00+136.6%
$5050000.00
Weighted average common shares outstanding used in basic per common share calculations (in shares)
$50469633000000.00-2.4%
$51703588000000.00-3.3%
$53455139000000.00-1.7%
$54371531000000.00
Plus: Dilutive securities (in shares)
617.02B+76.6%
349.37B+6.5%
327.93B-20.2%
411.00B
Weighted average common shares used in diluted per common share calculations (in shares)
$51086649000000.00-2.8%
$52581102000000.00-2.2%
$53783069000000.00-1.8%
$54782528000000.00
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Pro feature
Unlock 13 more years of annual history and full quarterly detail on Pro.
